TY  - JOUR
AU  - El Bekay, Rajaa
AU  - Coin-Aragüez, Leticia
AU  - Fernandez-Garcia, Diego
AU  - Oliva-Olivera, Wilfredo
AU  - Bernal-Lopez, Rosa
AU  - Clemente-Postigo, Mercedes
AU  - Delgado-Lista, Javier
AU  - Diaz-Ruiz, Alberto
AU  - Guzman-Ruiz, Rocio
AU  - Vazquez-Martinez, Rafael
AU  - Lhamyani, Said
AU  - Roca-Rodriguez, Maria Mar
AU  - Veledo, Sonia Fernandez
AU  - Vendrell, Joan
AU  - Malagon, Maria M
AU  - Tinahones, Francisco Jose
PY  - 2016
DO  - 10.1111/bph.13481
UR  - http://hdl.handle.net/10668/9931
T2  - British journal of pharmacology
AB  - Glucagon-like peptide-1 (GLP-1) analogues improve glycaemic control in type 2 diabetic (T2D) patients and cause weight loss in obese subjects by as yet unknown mechanisms. We recently demonstrated that the GLP-1 receptor, which is present in...
LA  - en
PB  - John Wiley & Sons
KW  - 3T3-L1 cells
KW  - Adipocytes
KW  - Animals
KW  - Cell differentiation
KW  - Diabetes mellitus, type 2
KW  - Exenatide
KW  - Gene expression
KW  - Genetic markers
KW  - Glucagon-like peptide 1
KW  - Humans
KW  - Mice
KW  - Obesity, morbid
KW  - Peptides
KW  - Pilot projects
KW  - Prospective studies
KW  - Venoms
TI  - Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.
TY  - research article
VL  - 173
ER  -